Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON43275
NL-OMON43275
Completed
N/A

*Characteristics of Quantitative Sensory Testing in ACNES patients compared to healthy controls; a pilot study.* - ACNES-QST

Maxima Medisch Centrum0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsabdominal wall painentrapment neuropathy10034606

Overview

Phase
N/A
Intervention
Not specified
Conditions
abdominal wall pain
Sponsor
Maxima Medisch Centrum
Enrollment
40
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Maxima Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • •ACNES group:
  • •\- Diagnosis of ACNES based upon 3 of 4 of the following characteristics:
  • •\- Sensory disturbances at triggerpoint site
  • •\- Positive Carnet\*s sign at triggerpoint site
  • •\- Positive Pinch sign at triggerpoint site
  • •\- Positive modified rectus sheath block (\>50% pain reduction)
  • •\- Unilateral
  • •\- Subject is at least 18 years old but younger than 55
  • •\- Subject is able and willing to comply with the follow\-up schedule and protocol
  • •\- Subject is able to provide written informed consent;Healthy controls:

Exclusion Criteria

  • •\- Female subject of childbearing potential is pregnant
  • •\- Significant comorbidity
  • •\- Previous abdominal open surgery with significant scars
  • •\- Skin lesions at target sites
  • •\- (Other) pain syndromes such as fibromyalgia, carpal tunnel syndrome, etc.
  • •\- Neurological disorders associated with sensory loss, e.g. diabetic neuropathy, MS, etc.
  • •\- Attention deficit disorders
  • •\- Opioid use or pain treatment regimen that can\*t be temporarily interrupted;Only for healthy controls:
  • •(history of) ACNES

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
The role of sensory parameters in predicting clinical outcome after lumbar discectomyNeurological - Other neurological disordersumbar radiculopathy with radicular painLumbar radiculopathy with radicular painSurgery - Other surgery
ACTRN12614001070628Dr Brigitte Tampin160
Active, Not Recruiting
Phase 2
Tetrodotoxin and quantitative sensory testing in healthy volunteersPainSigns and Symptoms
ISRCTN78737401eiden University Medical Center25
Active, Not Recruiting
Phase 1
Evaluation of sensory testing to measure the effects of tetrodotoxipainTherapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
CTIS2022-500318-24-00eiden University Medical Center25
Recruiting
N/A
Quantitative Sensory Testing (QST) in The Diagnostic & Therapeutic Process of patients with Painful Cervical Facet ArthropathyChronic Neck Pain1002321310005944
NL-OMON34812niversitair Medisch Centrum Sint Radboud92
Completed
N/A
Quantitative Sensory Testing (QST) as a tool to assess and quantify thoracic pain in patients with chronic interstitial lung disease (ILD)J84.9R07.4Interstitial pulmonary disease, unspecifiedChest pain, unspecified
DRKS00022978niversitätsmedizin Essen, Ruhrlandklinik79